We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AbbVie Presses Trade Commission to Ban Alvotech's Humira Biosimilar in the U.S.
AbbVie Presses Trade Commission to Ban Alvotech's Humira Biosimilar in the U.S.
AbbVie is pushing the International Trade Commission (ITC) to prevent Iceland-based biosimilar developer Alvotech from marketing its biosimilar candidate to AbbVie's blockbuster Humira (adalimumab).